Reaktionsgleichung
[C:1](=[O:4])([O-])[O-].[K+].[K+].CI.[Cl:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][C:11]=1[C:16]1[C:22]2[CH:23]=[C:24]([N+:27]([O-:29])=[O:28])[CH:25]=[CH:26][C:21]=2[NH:20][C:19](=O)[CH2:18][N:17]=1>CC(C)=O>[Cl:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][C:11]=1[C:16]1[C:22]2[CH:23]=[C:24]([N+:27]([O-:29])=[O:28])[CH:25]=[CH:26][C:21]=2[N:20]([CH3:19])[C:1](=[O:4])[CH2:18][N:17]=1Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
42.4 g of potassium carbonate and 18.5 ml of methyl iodide are added to a solution of 50 g (0.158 mol) of 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one in 600 ml of acetone and the mixture is stirred at room temperature for 16 hours. After filtering-off insoluble material, the filtrate is evaporated and the residue is taken up in methylene chloride. The organic phase is washed once with water, dried and evaporated, there being obtained 5-(o-chlorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one of melting point 220°.
Aufarbeitung
- customAfter filtering-off insoluble material, the filtrate is evaporated
- washThe organic phase is washed once with water
- customdried
- customevaporated
Quellen und Nachweise
- ORD-Eintrag
- ord-061f07e32c8342129964fa59931a8352
- Quelldatensatz
- uspto-grants-1984_09
- Patentnummer
- US04472435
Verknüpfte Notizen
Wird geladen…